Aortic vulnerability to COVID-19: is the microvasculature of vasa vasorum a key factor? A case report and a review of the literature
G. Faa, C. Gerosa, D. Fanni, D. Barcellona, G. Cerrone, G. Orrù, A. Scano, F. Marongiu, J.S. Suri, R. Demontis, M. Nioi, E. D’Aloja, G. La Nasa, L. Saba Division of Pathology, Department of Medical Sciences and Public Health, AOU of Cagliari, University of Cagliari, Cagliari, Italy. daniela.fanni@unica.it
Arterial thromboembolic complications reported in patients with COVID-19 infection suggested that SARS-CoV-2 can trigger atherosclerotic plaque vulnerability. While endothelial cells in healthy subjects protect against thrombus formation, after injury they show prothrombotic activity. In addition, it has been hypothesized that “cytokine storm” might stimulate the production of neo-platelets triggering an abnormal “immunothrombosis” responsible for the hypercoagulable state induced in COVID-19 patients. The aim of this study is to report a case of severe COVID-19 infection characterized by the occurrence of microthrombosis in the vasa vasorum of the aorta.
A 67-year-old male patient, in good health status and without comorbidities, who underwent a severe COVID-19 infection with fatal outcome, showed scattered aortic atherosclerotic plaques, characterized by multiple occlusive micro-thromboses in the vasa vasorum, spread out lymphocytic infiltrates and foci of endotheliitis and endothelial detachment.
This case report confirms the previously described thrombotic involvement of vasa vasorum in COVID-19. The occurrence of the synchronous damage involving both the lumen surface (endothelial dysfunction, endotheliitis and endothelial detachment) and the adventitia (inflammation and occlusive thrombosis of vasa vasorum) could be the key points related to the fatal outcome of the SARS-CoV-2 patients. In our opinion, vasa vasorum thrombosis may thus initiate an atherogenic process that could be characterized by a much more rapid development.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
G. Faa, C. Gerosa, D. Fanni, D. Barcellona, G. Cerrone, G. Orrù, A. Scano, F. Marongiu, J.S. Suri, R. Demontis, M. Nioi, E. D’Aloja, G. La Nasa, L. Saba
Aortic vulnerability to COVID-19: is the microvasculature of vasa vasorum a key factor? A case report and a review of the literature
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 20
Pages: 6439-6442
DOI: 10.26355/eurrev_202110_27018